Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026

About this update from Opus Genetics, Inc.

[{"type":"image","alt":"Opus Genetics, Inc.","displaySize":"","headline":null,"caption":"Opus Genetics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":129,"url":"https://media.zenfs.com/en/globenewswire.com/df50c41a115dee0675cbe3b477dc2db0"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/8o4zybgloi24hra3hobbTg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE4MTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/df50c41a115dee0675cbe3b477dc2db0","width":300,"height":129}},"lazy":false},{"type":"text","content":"RESEARCH TRIANGLE PARK, N.C., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today announced that members of its leadership team will participate in several leading ophthalmology and industry conferences.","length":422,"tagName":"p"},{"type":"text","content":"Collaborative Community on Ophthalmic Innovation (CCOI)","length":55,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Topic: Opus Genetics leadership will participate in discussions focused on emerging treatment approaches and clinical insights in retinal disease.","length":146,"tagName":"p"}]},{"val":[{"type":"text","content":"Date: February 3-4, 2026","length":24,"tagName":"p"}]},{"val":[{"type":"text","content":"Location: Hong Kong","length":19,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":189,"olType":false},{"type":"text","content":"Asia-Pacific Academy of Ophthalmology Congress (APAO)","length":53,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Topic: The Company will engage with the global ophthalmology community to discuss advances in gene therapy and evolving strategies for treating inherited retinal disorders.","length":172,"tagName":"p"}]},{"val":[{"type":"text","content":"Date: February 5-8, 2026","length":24,"tagName":"p"}]},{"val":[{"type":"text","content":"Location: Hong Kong","length":19,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":215,"olType":false},{"type":"text","content":"Advanced Therapies Week Conference","length":34,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Title: Building scalable viral vector manufacturi...

More updates from Opus Genetics, Inc.